Reinhard Vogt was most recently the Executive VP and Member of the Board of Sartorius Stedim Biotech S.A., he brings a wealth of industry knowledge, technology deal-side expertise and numerous technology licenses, acquisitions and integrations derived from one of the industry’s largest players. What this means to investors and portfolio companies is a winning combination of commercial and operational support. Reinhard plays a critical role in Dynamk Capital in assessing the commercial viability of potential portfolio companies and which commercial model is best and sits on the board of several of these portfolios.